Search
Explore Johnson Matthey's website
Showing results 409-416 / 483
The importance of solid form science in modern drug development
As the pharmaceutical industry turns to more complex chemical entities with increased molecular weight, enhancing solubility is becoming a key drug development challenge.
ExploreAdvancing the hydrogen economy from production to application
What are JM's activities across the hydrogen value chain? JM's CTO, Maurits van Tol, speaks to Hydrogen Central.
ExploreJohnson Matthey partners with Immunomedics to develop life-saving cancer treatment
News: Johnson Matthey has announced a strategic manufacturing partnership for the large-scale production of the drug-linker used in Immunomedics’ lead antibody-drug conjugate.
ExploreIf hydrogen is the answer to energy security, let's talk carbon, not colour
Maurits van Tol, Chief Technology Officer, explains why we need a change of language to enable development of a global clean hydrogen economy.
ExploreFive surprising ways to increase living standards sustainably
From making plastics from plants, to cleaning up deliveries - Suzanne Ellis explains how we can make the industries associated with our modern living standards more sustainable.
Explore
